Author

Lawrence Almanzar

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center

Observed institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center

OpenAlex ID: A5040103470

Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma

2017 · Stefan K. Barta, Rishi Jain, et al. · Clinical Lymphoma Myeloma & Leukemia · 9

PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple Myeloma

2014 · Stefan Klaus Barta, Amitabha Mazumder, et al. · Transplantation and Cellular Therapy · 1

PK-Directed Intravenous Busulfan In Combination With High-Dose Melphalan and Bortezomib As Conditioning Regimen For Patients With Multiple Myeloma

2013 · Stefan K Barta, Amitabha Mazumder, et al. · Blood

Works count: 3

Citation count: 10

H-index: 1

I10-index: